ABBVIE INC. Share Price
NYSE: ABBV | Mega CapABBVIE INC. Stock Performance
ABBVIE INC. Share Price Today
As of 19 September 2026, ABBVIE INC.'s share price is $263.89. The stock opened at $263.01, compared to its previous close of $264.13. During today's trading session, ABBVIE INC.'s share price traded between $263.00 and $266.29, with an average price of $264.64. Over the past 52 weeks, the stock has recorded a high of $267.45 and a low of $191.33. In terms of performance, ABBVIE INC.'s share price has risen by 21.35% over the last six months and is up 13.93% on a year-on-year basis.
ABBVIE INC. Share Price Chart
ABBVIE INC. Quarterly Profit & Loss
All figures in USD
ABBVIE INC. Annual Profit & Loss
All figures in USD
About ABBVIE INC.
AbbVie Inc., based in North Chicago, Illinois, is a global biopharmaceutical company. Spun off from Abbott Laboratories in 2013, AbbVie develops drugs for immunology, oncology, neuroscience, and virology. Its flagship products include Humira, Rinvoq, and Skyrizi. AbbVie also acquired Allergan, expanding into aesthetics and eye care.
ABBVIE INC. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Sep 2026 | $260.84 | $263.86 | +2.22% |
Aug 2026 | $251.95 | $258.14 | +2.89% |
Jul 2026 | $250.81 | $250.88 | -0.17% |
Jun 2026 | $215.88 | $251.31 | +15.41% |
May 2026 | $209.44 | $217.76 | +3.02% |
Apr 2026 | $218.48 | $211.38 | -2.79% |
Mar 2026 | $234.18 | $217.46 | -6.36% |
Feb 2026 | $224.78 | $232.22 | +4.14% |
Jan 2026 | $228.21 | $223.00 | -2.40% |
Dec 2025 | $227.70 | $228.48 | +0.31% |
Nov 2025 | $217.10 | $227.77 | +4.43% |
Oct 2025 | $233.92 | $218.10 | -5.84% |